CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Industry Satellite Symposia
Calendar Export
Individualizing therapeutic decision-making for patients with HR+/HER2- EBC
(ID 337)
Lecture Time
19:05 - 19:15
Speakers
J. Cortes Castan
(Barcelona, Spain)
Session Name
CCO - CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes
Room
Channel 1
Date
Wed, 05.05.2021
Time
19:00 - 20:00